Now, some oral agents such as sulfonylureas, metformin, sitagliptin phosphate (SP), and injection of insulin are extensively used in the treatment of type 2 diabetes mellitus (T2DM). The gene discussed is INS; the disease is type 2 diabetes mellitus.